Oct 29, 2024, 15:22
Hope Rugo: Optimizing Therapy for Patients with Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities
Hope Rugo, Director of Breast Oncology and Clinical Trials Education at the UCSF, shared a post on X:
”Join us! with Research To Practice and Komal Jhaveri: LIVE WEBINAR: October 31, 2024, 5 – 6 PM ET. Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 22, 2025, 05:18
Feb 22, 2025, 05:15
Feb 22, 2025, 05:05
Feb 22, 2025, 04:54
Feb 22, 2025, 04:49
Feb 22, 2025, 04:33
Feb 22, 2025, 04:29